Clinical TrialsSearch results
Number of results: 551
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Open-label, randomized, controlled study evaluating dose-escalation of peginterferon alpa-2b plus ribavirin in aged patients with chronic hepatitis C
- Chronic hepatitis C
- Okayama University Hospital
- 2014-10-01
Other
- An open-label, randomized, controlled trial comparing different dosing regimens with peginterferon alpha-2a plus ribavirin in patients with chronic hepatitis C.
- Chronic hepatitis C with serogroup 1 and high viral load (>= 100 KIU/mL).
- Okayama University Hospital
- 2008-02-29
Other
- A randomized phase II study designed to compare toxicity and dose intensity between four-week versus three-week schedule of gemcitabine for advanced pancreatic cancer
- Advanced nonresectable pancreatic cancer
- Okayama University Hospital
- 2008-01-08
Other
- A prospective cohort study of peginterferon alpha-2a plus ribavirin treatment in patients with chronic hepatitis C.
- Chronic hepatitis C
- Okayama University Hospital
- 2008-02-29
Other
- Gefitnib monotherapy in patients with post-operative recurrent non-small-cell lung cancer with the EGFR mutation: a Phase II study
- non small cell lung cancer with EGFR mutation
- Okayama University Cancer and Thoracic Surgery
- 2006-04-24
Other
- Therapeutic effect of an immunosupp-ressive agent, mizoribine in patients with the progression of renal failure in diabetic nephropathy
- Diabetic nephropathy
- Okayama University
- 2009-03-31
Other
- Randomized, comparative clinical study of cisplatin and docetaxel combination chemotherapy and mitomycin, vindesine and cisplatin (MVP) combination chemotherapy with concurrent thoracic radiation therapy for locally advanced unresectable non-small-cell lung cancer (OLCSG0007)
- inoperable locally advanced non-small-cell lung cancer
- Okayama Lung Cancer Study Group (OLCSG)
- 2005-09-12
Other
- Randomized comparative study of cisplatin, docetaxel, and irinotecan versus cisplatin and docetaxel in patients with stage IIIB or stage IV non-small cell lung cancer (OLCSG 0403)
- Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- Okayama Lung Cancer Study Group (OLCSG)
- 2005-09-13
Other
- Randomized phase II trial of S-1 plus docetaxel combination versus single-agent docetaxel in platinum-pretreated patients with non-small-cell lung cancer
- platinum-pretreated patients with non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12
Other
- Phase II study of topotecan and cisplatin for elderly small-cell lung cancer
- Elderly small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12